NCT02183597
Withdrawn
Not Applicable
Whole-body MRI for the Detection of Metastasis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Norwegian University of Science and Technology
- Primary Endpoint
- Number of metastasis in skeleton
- Status
- Withdrawn
- Last Updated
- 9 years ago
Overview
Brief Summary
Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cancer patient
Exclusion Criteria
- •Poor general condition
- •Pacemaker or other MRI contraindications
Outcomes
Primary Outcomes
Number of metastasis in skeleton
Time Frame: Baseline and after 6 months
Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease
Similar Trials
Completed
Not Applicable
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer MetastasesBreast CancerNCT00592462M.D. Anderson Cancer Center32
Unknown
Not Applicable
Improving Diagnosis and Treatment of Metastatic Advanced Prostate CancerAdvanced Prostate CarcinomaNCT04984395Royal Marsden NHS Foundation Trust50
Unknown
Not Applicable
Computer Assisted Early Detection of Liver Metastases From fMRI MapsMetastatic Colorectal CancerNCT00435097Hadassah Medical Organization
Active, not recruiting
Not Applicable
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition SyndromesLi-Fraumeni SyndromeNCT02950987Dana-Farber Cancer Institute150
Unknown
Not Applicable
Development and Validation of Advanced MRI Methods for Clinical ApplicationsBrain TumorNCT03264300St. Joseph's Hospital and Medical Center, Phoenix220